Zenotech Laboratories Ltd has informed BSE that the Board of directors of the Company on April 01, 2015 appointed Smt. Kavita Shah and Mr. Vijay Agarwal as Additional Directors of the Company with immediate effect. Money Control, 3 weeks ago
Zenotech Laboratories announces resignation of Director cum Chairman - Business Standard, 4 weeks ago
Zenotech Laboratories' director K. L. Khurana resigns - Money Control, 4 weeks ago
1 images for "zenotech laboratories"
Sales decline 15.71% to Rs 0.59 crore Net Loss of Zenotech Laboratories reported to Rs 11.12 crore in the quarter ended December 2014 as against net loss of Rs 6.87 crore during the previous quarter ended December 2013. Sales declined 15.71% to Rs 0.59 crore ...Business Standard, 2 months ago
Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun Pharma made an open offer to buy 9.7 million shares at Rs. 20.87 pursuant to the Ranbaxy merger deal. Zenotech Laboratories was locked at the 5% upper limit at Rs. 45.25 after Sun ...India Infoline, 3 weeks ago
Zenotech Laboratories touched its 52-week high in trade today, with the scrip hitting an upper circuit limit of 5 per cent in a reaction to Sun Pharmaceutical Industries' open offer to acquire nearly 9.7 mn shares in the company at Rs 20.87 per share. A ...Economic Times, 3 weeks ago Zenotech hits upper circuit on Sun's open offer Economic Times, 3 weeks ago
/PRNewswire/ -- Biosimilar drug producers - your guide to those companies' activities and prospects What does the future hold for makers of biosimilar medicines? Discover those companies' outlooks from 2015. You see results, trends, opportunities ...TickerTech.com, 3 weeks ago
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases that are characterized by excessive number of ...GaBi Online, 1 month ago
on your WebpageAdd Widget >Get your members hooked!